InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.03
(
0.61%
)
US TECH 100
19,748.80
(
0.07%
)
Dow Jones
42,863.86
(
0.97%
)
Brent Oil
77.87
(
0.52%
)
Bitcoin
64,592.49
(
2.77%
)
Post# of 253357
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: DewDiligence post# 187955

Friday, 02/27/2015 2:42:10 PM

Friday, February 27, 2015 2:42:10 PM

Post# of 253357
>> RTH258

Clearly a long-term threat to Eyelea here. Better efficacy (if only marginally) plus less frequent administration makes for a clearly superior drug.

I sold my REGN based on this news. Might be a year or more early, but who knows.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up